Harbin Medisan Pharmaceutical Co., Ltd. at its Annual General Meeting of 2021 on 17 May 2022 approved the profit distribution for 2021. The company announced final cash dividend/10 shares (tax included) of CCNY 3.20000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.14 CNY | +3.16% | -12.70% | -33.04% |
1st Jan change | Capi. | |
---|---|---|
-33.04% | 390M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 002900 Stock
- News Harbin Medisan Pharmaceutical Co., Ltd.
- Harbin Medisan Pharmaceutical Co., Ltd. Approves Final Cash Dividend Proposal for 2021